Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3020047	s-hibab	— (—)	36	45	100.00%	Distribution not available
3020047	s-hibab	mg/l (—)	31	38	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

13.11

31.95

1.5

1.1

—

Immunodeficiencies

+∞

28.19

1.5

0.0

—

Immunodeficiency with predominantly antibody defects

+∞

18.81

1.7

0.0

—

Other and unspecified immunodeficiencies with predominantly antibody defects

+∞

12.55

1.8

0.0

—

Pneumonias (Asthma/COPD co-morbidities)

5.82

12.39

1.5

1.2

—

All pneumoniae

5.43

11.60

1.5

1.2

—

Kela reimbursement Agammaglobulinemia (D80-84)

+∞

11.53

1.5

0.0

—

Intestinal infectious diseases

5.52

11.47

1.3

1.4

—

Pneumonia, organism unspecified

5.97

11.45

1.6

1.3

—

Influenza and pneumonia

5.33

11.16

1.5

1.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

5.81

10.75

1.3

1.5

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

5.25

10.69

1.6

1.2

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

12.78

9.84

1.6

1.1

—

12.78

9.84

1.6

1.1

—

Cough

12.38

9.79

1.6

1.4

—

Acute upper respiratory infections

10.64

9.18

1.5

1.3

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

4.75

9.07

1.6

1.2

—

Acute upper respiratory infections of multiple and unspecified sites

13.18

8.95

1.6

1.3

—

Acute sinusitis

22.21

8.55

1.3

1.4

—

Immunodeficiency associated with other major defects

+∞

8.45

1.3

0.0

—

Other immunodeficiencies

+∞

8.36

1.4

0.0

—

ILD medications: immunosuppressive drugs

6.97

7.68

1.6

1.4

—

Persons encountering health services for specific procedures and health care

4.11

7.68

1.5

1.3

—

Other bacterial diseases

4.64

7.66

1.5

1.4

—

Fever of other and unknown origin

9.54

7.65

1.5

1.2

—

Defects in the complement system

+∞

7.32

1.3

0.0

—

Other septicaemia

8.98

7.07

1.4

1.3

—

Any reimbursement code in KELA

10.74

6.97

1.5

1.0

—

COPD/asthma related infections

8.90

6.81

1.7

1.1

—

COPD/asthma/ILD related infections

8.90

6.81

1.7

1.1

—

Septicaemia

6.80

1.3

1.4

—

Explicit Sepsis

6.79

1.3

—

Any gastric operation

5.33

6.58

1.5

1.3

—

GASTRO-related operations

5.33

6.58

1.5

1.3

—

Asthma/COPD (KELA code 203)

4.20

6.58

1.2

1.5

—

7.32

6.58

1.6

1.3

—

ILD medications: prednisolone, methylprednisolone, prednisone

4.30

6.58

1.4

1.3

—

Asthma (diagnoses ohter than nonallergic)

4.15

6.54

1.2

1.4

—

Continuous positive airway pressure

13.25

6.52

1.2

1.1

—

Asthma, hospital admission 2, infections

5.34

6.46

1.3

1.4

—

Asthma-related infections

5.34

6.46

1.3

1.4

—

Diarrhoea and gastroenteritis of presumed infectious origin

3.99

6.43

1.3

1.4

—

Asthma-related pneumonia

7.36

6.39

1.4

—

Asthma, hospital admissions 3, pneumonia

7.36

6.39

1.4

—

Asthma-related pneumonia or sepsis

7.36

6.39

1.4

—

Other bacterial diseases

3.97

6.29

1.5

1.3

—

Nonhereditary hypogammaglobulinemia

+∞

6.26

1.5

0.0

—

Other/unspecified cytomegaloviral diseases

+∞

6.26

1.2

0.0

—

Cytomegalovirus infection, IBD co-morbidity

+∞

6.26

1.2

0.0

—

Cytomegaloviral disease

+∞

6.26

1.2

0.0

—

Asthma, hospital admissions , main diagnosis only

3.87

6.12

1.2

1.4

—

Care involving use of rehabilitation procedures

5.39

6.12

1.6

1.3

—

Bronchitis

5.95

6.09

1.5

1.3

—

5.27

6.09

1.4

—

Transplanted organ and tissue status

12.52

6.07

1.7

1.3

—

Otitis media, unspecified

8.51

5.93

1.3

—

Lack of expected normal physiological development

12.60

5.91

1.7

1.3

—

Acute suppurative otitis media

7.14

5.80

1.5

1.3

—

Hypoplasia of dental enamel , including avohilmo

7.82

5.71

1.8

1.3

—

Other diseases of pleura

10.96

5.59

1.5

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

5.49

5.58

1.4

—

Molar incisor enamel hypoplasia

6.64

5.57

1.8

1.3

—

ILD medications

3.56

5.45

1.5

1.3

—

Inflammatory bowel disease treatment related agents

3.66

5.20

1.5

1.4

—

Other special examinations and investigations of persons without complaint or reported diagnosis

8.68

5.19

1.7

1.6

—

Congenital malformations, deformations and chromosomal abnormalities

4.94

5.12

1.4

—

Abnormalities of breathing

4.36

5.10

1.1

1.4

—

Viral and other specified intestinal infections

6.43

5.10

1.2

1.5

—

Examination and observation for other reasons

9.09

5.08

1.3

1.6

—

Exclusion endpoint for clefts

13.43

5.08

1.1

1.5

—

Infections of the skin and subcutaneous tissue

4.79

5.06

1.5

1.4

—

Disorders of psychological development

5.75

5.05

1.6

1.2

—

Viral and other specified intestinal infections

7.16

5.04

1.2

1.6

—

Hypoplasia of dental enamel

10.19

5.04

1.9

1.3

—

Certain infectious and parasitic diseases

4.05

5.03

1.6

1.2

—

Disorders of other endocrine glands

4.76

5.02

1.4

—

Slow fetal growth and fetal malnutrition

11.69

4.79

1.3

1.7

—

Delayed milestone in childhood

5.75

4.66

1.6

1.4

—

Covid-19 confirmed case

7.14

4.64

1.6

1.5

—

Suppurative and unspecified otitis media

5.60

4.58

1.4

1.3

—

Other specified congenital malformation syndromes affecting multiple systems

14.12

4.58

1.1

1.6

—

Other acute lower respiratory infections

4.60

4.58

1.5

1.4

—

5.50

4.57

1.3

1.5

—

Chronic lower respiratory diseases

3.23

4.55

1.3

1.4

—

Azathioprine

10.01

4.51

1.9

1.3

—

Chronic sinusitis

9.99

4.51

1.3

1.8

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

4.47

4.49

1.2

1.5

—

Codes for special purposes

5.21

4.44

1.5

1.3

—

Provisional assignment of new diseases of uncertain etiology

5.21

4.44

1.5

1.3

—

ILD medications: azathioprine

8.90

4.27

1.9

1.2

—

Mental retardation, excluding more controls

11.38

4.20

1.6

1.2

—

Respiratory and cardiovascular disorders specific to the perinatal period

4.92

4.17

1.2

1.5

—

Other congenital malformations

5.89

4.12

1.1

1.4

—

Oral corticosteroids

4.82

4.09

1.3

1.4

—

Dyspnoea

3.57

4.09

1.1

1.6

—

Symptoms and signs involving the circulatory and respiratory systems

3.76

4.08

1.5

1.4

—

Cellulitis

8.00

4.05

1.8

1.4

—

Gastrointestinal diseases

5.01

4.05

1.6

1.2

—

Nephropathy related operations

10.01

4.01

1.3

1.7

—

Implicit viral Sepsis

10.00

4.00

1.7

1.1

—

L04AD Calcineurin inhibitors

6.44

3.98

1.4

1.5

—

Acute bronchitis

4.53

3.97

1.6

1.4

—

Speech and linguistic disorders, excluding more controls

6.52

3.97

1.9

1.2

—

First line medication for Crohn's disease

3.02

3.96

1.4

—

Headache

5.17

3.95

1.4

1.2

—

Cardiovascular diseases

3.12

3.94

1.3

1.4

—

Motor disorders, excluding more controls

7.65

3.91

1.8

1.2

—

Speech and linguistic disorders

4.44

3.89

1.7

1.3

—

Childhood allergy (age < 16)

4.50

3.85

1.6

1.2

—

Specific developmental disorder of motor function

7.18

3.80

1.8

1.3

—

Noninfective enteritis and colitis

4.28

3.80

1.2

1.6

—

Pain, not elsewhere classified

8.75

3.77

1.4

1.1

—

Abnormalities of heart beat

11.77

3.72

1.2

1.6

—

Other endocrine disorders

5.06

3.68

1.3

1.4

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3.08

3.67

1.4

—

Motor disorders

6.70

3.66

1.8

1.3

—

Other viral diseases

3.80

3.65

1.6

1.3

—

4.89

3.59

1.1

1.5

—

Other viral diseases

3.99

3.57

1.6

1.3

—

Disorders of refraction and accommodation

3.99

3.57

1.2

1.4

—

Other congenital malformations

4.77

3.55

1.1

1.5

—

Other noninfective gastroenteritis and colitis

4.76

3.55

1.1

1.6

—

Procreative management

3.74

3.51

1.4

1.3

—

L04AA Selective immunosuppressants

6.16

3.50

1.4

1.3

—

Mycoses

10.00

3.49

1.3

1.7

—

Symptoms and signs concerning food and fluid intake

9.99

3.49

1.2

—

Disorders of tooth development and eruption

6.48

3.47

1.4

1.1

—

Neurological diseases, wide definition

5.58

3.47

1.5

1.2

—

Bacterial Sepsis

6.21

3.42

1.8

1.2

—

Other problems related to primary support group, including family circumstances

4.12

3.40

1.2

1.5

—

Molar incisor enamel hypoplasia, with caries

7.08

3.36

2.1

1.4

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

7.01

3.36

1.1

1.4

—

Convulsions, not elsewhere classified

6.91

3.33

1.6

1.2

—

Dorsopathies

3.18

3.32

1.5

1.4

—

Aplastic and other anaemias

5.74

3.31

1.1

1.3

—

Respiratory distress of newborn

4.97

3.30

1.2

1.5

—

Caries of enamel

3.06

3.28

1.7

1.2

—

Second line medication for Crohn's disease

3.93

3.28

1.6

1.4

—

L04AX Other immunosuppressants

3.93

3.28

1.6

1.4

—

Viral infections characterized by skin and mucous membrane lesions

3.93

3.28

1.5

—

Persons with potential health hazards related to communicable diseases

3.39

3.27

1.3

1.4

—

Parasetamol

5.07

3.26

1.5

1.6

—

Invasive ventilation

8.59

3.26

1.3

1.1

—

Other respiratory disorders and diseases

8.58

3.26

1.7

1.0

—

Other diseases of the respiratory system

8.58

3.26

1.7

1.0

—

Other disorders of lacrimal gland

8.57

3.26

1.7

1.4

—

Diseases of liver

8.57

3.26

1.3

1.7

—

Liquid cancers, helper endpoint

6.78

3.22

1.9

1.0

—

Chronic kidney disease

8.41

3.22

1.2

1.7

—

Tonsillectomy and adenotomy

2.78

3.19

1.4

—

Osteopathies and chondropathies

4.66

3.16

1.4

1.6

—

Certain conditions originating in the perinatal period

4.70

3.16

1.4

1.5

—

Intestinal infectious diseases

2.86

3.15

1.3

1.4

—

Asthma, including avohilmo

2.66

3.12

1.3

1.4

—

Anaemias

4.90

3.08

1.3

1.2

—

Other and unspecified anaemias

6.06

3.07

1.0

1.3

—

Other anaemias

6.05

3.06

1.0

1.3

—

Other diseases of blood and blood-forming organs, wide

7.50

3.05

1.5

—

Malaise and fatigue

6.26

3.03

1.4

1.1

—

Antihypertensive medication - note that there are other indications

2.95

3.03

1.5

1.4

—

Specific development disorders of scholastic skills

7.42

3.02

1.7

1.6

—

Short stature, not elsewhere classified

4.42

3.02

1.3

1.4

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

3.30

2.98

1.4

—

Disorders of speech understanding and production

5.74

2.97

1.4

—

Metabolic disorders

2.95

2.96

1.2

1.5

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

5.67

2.95

1.9

1.6

—

Nausea and vomiting

4.20

2.93

1.4

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

3.73

2.88

1.3

1.5

—

Personal history of other diseases and conditions

5.37

2.85

1.4

1.2

—

Conjunctivitis

2.72

2.82

1.7

1.3

—

Acute bronchiolitis

4.06

2.81

1.4

—

Chronic diseases of tonsils and adenoids

2.93

2.77

1.3

1.4

—

Cardiovascular diseases (excluding rheumatic etc)

2.63

2.76

1.4

—

Implicit bacterial Sepsis

8.86

2.76

1.6

1.2

—

Kidney transplant status

8.35

2.75

1.2

1.7

—

Primary_lymphoid and hematopoietic malignant neoplasms

8.34

2.75

2.2

1.0

—

Other/unspecified dorsalgia

8.26

2.73

1.6

2.0

—

Pain in throat and chest

3.75

2.68

1.5

1.4

—

Other viral diseases, not elsewhere classified

3.43

2.67

1.8

1.3

—

Persons encountering health services in circumstances related to reproduction

2.82

2.66

1.7

1.3

—

Specific development disorders of speech and language

4.82

2.64

1.6

1.3

—

Dental caries

5.77

2.61

2.2

1.1

—

Disorders of conjunctiva

2.61

1.7

1.3

—

Any mental disorder

2.80

2.59

1.6

1.3

—

Diseases of middle ear and mastoid

3.41

2.58

1.5

1.4

—

Other viral diseases, not elsewhere classified

3.59

2.56

1.8

1.3

—

Noninflammatory disorders of female genital tract

4.11

2.56

1.4

1.5

—

Nonsuppurative otitis media

4.07

2.55

1.5

1.3

—

Congenital malformations of aortic and mitral valves

7.16

2.55

1.6

—

Dialysis, with operation codes

7.15

2.55

1.6

1.7

—

Cerebrovascular diseases (FINNGEN)

6.06

2.55

1.7

1.4

—

Disorders of lacrimal system

5.44

2.53

1.7

1.8

—

Acute tubulo-interstitial nephritis

3.06

2.52

1.5

1.4

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3.98

2.51

1.3

1.4

—

Dorsalgia

3.27

2.50

1.5

1.4

—

Implicit bacterial Sepsis

7.20

2.49

1.6

1.2

—

Other disorders of fluid, electrolyte and acid-base balance

6.80

2.46

1.0

1.4

—

Renal failure

5.30

2.45

1.2

1.6

—

Low back pain

3.59

2.44

1.6

1.4

—

General symptoms and signs

3.24

2.44

1.9

1.2

—

Use of hypnotics and sedatives

3.16

2.44

1.5

1.3

—

Vasomotor and allergic rhinitis

3.40

2.43

1.2

1.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

3.36

2.40

1.3

1.5

—

Congenital malformations of the circulatory system

3.36

2.39

1.3

1.5

—

Congenital malformations of heart and great arteries

3.36

2.39

1.3

1.5

—

Substance abuse, excluding more controls

5.11

2.37

1.2

1.5

—

Implicit Sepsis

3.18

2.37

1.6

1.3

—

Embedded teeth, including avohilmo

6.26

2.37

1.6

1.9

—

Astigmatism

6.25

2.37

1.4

1.9

—

Other congenital malformations of the digestive system

4.10

2.34

1.3

1.4

—

Other congenital malformations of the digestive system

4.10

2.34

1.3

1.4

—

Other disorders starting during childhood or adolecense, excluding more controls

4.80

2.31

1.7

1.2

—

Hyperkinetic disorders, excluding more controls

5.98

2.29

1.2

1.4

—

Bacterial infection, other or unspecified

4.05

2.28

1.4

1.2

—

STROKE

5.10

2.27

1.5

1.6

—

Cutaneous abscess, furuncle and carbuncle

4.62

2.27

1.5

—

Hypermetropia

4.62

2.27

1.3

1.5

—

All anxiety disorders

3.23

2.24

1.2

1.5

—

Mental retardation, wide definition

3.87

2.24

1.6

1.3

—

Mental retardation

3.87

2.24

1.6

1.3

—

All chronic kidney diseases

3.20

2.23

1.2

1.5

—

Implicit Sepsis

3.23

2.23

1.6

1.4

—

Certain infectious and parasitic diseases

3.47

2.22

1.6

1.4

—

Impetigo

5.57

2.21

1.0

1.4

—

Systemic connective tissue disorders

5.56

2.21

2.0

1.4

—

Other disorders of ear

2.62

2.16

1.5

1.4

—

Opioids

3.06

2.15

1.2

1.6

—

Atopic dermatitis, strict definition

2.80

2.14

1.6

1.3

—

Other diseases of intestines

2.27

2.12

1.3

1.4

—

Bacterial infection, other or unspecified

3.70

2.11

1.4

1.2

—

Tramadol

3.91

2.09

1.1

1.6

—

Symptoms and signs involving the skin and subcutaneous tissue

2.94

2.09

1.1

1.5

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.82

2.08

1.6

1.3

—

Other diseases of upper respiratory tract

2.43

2.07

1.4

—

Left ventricular outflow tract obstruction, narrow definition

5.01

2.07

1.6

1.4

—

Deforming dorsopathies

5.00

2.07

1.6

—

All influenza

5.00

2.07

1.6

1.3

—

Urticaria and erythema

2.90

2.07

1.1

1.5

—

Other and unspecified effects of external causes

3.50

2.05

1.1

1.6

—

Other reaction to severe stress, and adjustment disorders

4.00

2.04

1.5

1.7

—

Substance abuse

4.03

2.03

1.2

1.8

—

Persons encountering health services in other circumstances, wide

2.40

2.02

1.4

—

Stroke, excluding SAH

5.21

2.01

1.6

1.1

—

Psychiatric diseases

2.61

2.00

1.5

1.3

—

Cardiac arrhythmias

3.25

2.00

1.4

1.6

—

Haemorrhagic and haematological disorders of fetus and newborn

3.08

1.99

1.3

1.4

—

Cerebrovascular diseases

3.51

1.96

1.6

1.5

—

Other dorsopathies, not elsewhere classified

2.88

1.96

1.4

—

Other arthritis (FG)

4.55

1.94

1.2

1.7

—

Candidiasis

4.55

1.94

1.8

1.5

—

Medical observation and evaluation for suspected diseases and conditions

4.38

1.94

1.3

1.6

—

Temporomandibular joint disorders, including avohilmo

3.29

1.93

1.3

1.5

—

Allergic conjunctivitis

2.74

1.93

1.7

1.4

—

Renal tubulo-interstitial diseases

2.41

1.93

1.4

—

Complications of procedures, not elsewhere classified

3.01

1.92

1.3

1.5

—

Paroxysmal tachycardia

4.65

1.92

1.6

1.7

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.71

1.90

1.5

1.4

—

Mental and behavioural disorders due to psychoactive substance use

3.71

1.89

1.2

1.8

—

Excessive, frequent and irregular menstruation

3.49

1.86

1.4

1.5

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.67

1.85

1.4

1.3

—

Epilepsy

2.85

1.85

1.8

1.4

—

Contact with and exposure to communicable diseases

2.64

1.85

1.4

—

Other nutritional deficiencies

2.65

1.85

1.3

1.5

—

Diseases of the digestive system

2.84

1.85

1.3

1.5

—

Focal epilepsy

3.53

1.83

1.7

1.5

—

Autoimmune diseases related-to ILD

2.65

1.83

1.4

—

Sensorineural hearing loss

3.70

1.80

1.2

1.5

—

Anxiety disorders, excluding more controls

3.25

1.80

1.4

—

Congenital malformations of great arteries

3.48

1.80

1.5

—

Crossbite

3.08

1.80

1.6

1.5

—

Symptoms and signs involving the digestive system and abdomen

2.26

1.79

1.4

1.3

—

Viral infections characterized by skin and mucous membrane lesions

2.28

1.77

1.4

—

Allergic rhinitis

2.54

1.77

1.3

1.4

—

Embedded and impacted teeth

3.04

1.75

1.6

1.4

—

Other functional intestinal disorders

2.53

1.75

1.4

1.5

—

Congenital malformations of cardiac septa

2.95

1.73

1.4

—

Mycoses

2.52

1.73

1.4

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2.68

1.72

1.8

1.3

—

Mouth breathing

2.66

1.72

1.1

1.4

—

Adverse effects, not elsewhere classified

3.85

1.71

1.2

1.6

—

Other intervertebral disc disorders

4.30

1.71

1.2

1.1

—

Focal epilepsy, strict definition

3.85

1.71

1.8

1.5

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

2.62

1.70

1.4

—

Other disorders starting during childhood or adolescence

2.89

1.70

1.6

1.4

—

Stroke, including SAH

4.03

1.69

1.6

1.3

—

Hernia

2.58

1.68

1.2

1.5

—

Tooth eruption problems

2.85

1.67

1.4

1.6

—

Contraceptive management

3.90

1.64

1.2

1.6

—

Reimbursement for rheumatic diseases

2.79

1.64

1.0

1.6

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.11

1.63

1.7

1.4

—

Disturbance of activity and attention

3.10

1.62

1.2

1.5

—

Diseases of the eye and adnexa

2.31

1.62

1.7

1.3

—

Hard cardiovascular diseases

2.34

1.60

1.5

—

Other anxiety disorders

3.06

1.58

1.2

1.6

—

Abnormal findings on examination of blood, without diagnosis

3.53

1.58

1.2

1.3

—

Irregular menses

2.76

1.58

1.1

1.5

—

Other symptoms and signs involving the nervous and musculoskeletal systems

2.69

1.58

1.9

1.3

—

All kidney diseases

2.11

1.57

1.4

—

Intracranial trauma

2.56

1.57

1.4

1.3

—

Concussion

2.72

1.56

1.1

1.3

—

Urticaria

2.59

1.51

1.1

1.5

—

Disorders of eyelid, lacrimal system and orbit

2.53

1.50

1.4

—

Sleep apnoea, including avohilmo

2.71

1.49

1.4

—

Other disorders of skin and subcutaneous tissue

2.59

1.49

1.1

1.5

—

Genitourinary diseases

2.30

1.47

1.4

—

Periapical abscess

3.13

1.44

1.6

1.7

—

Atrial septal defect

3.11

1.43

1.6

1.5

—

Lower back pain or/and sciatica

2.35

1.42

1.6

1.4

—

Hypertension

2.31

1.39

1.6

1.4

—

Anxiety (asthma-related co-morbidities)

2.46

1.38

1.1

1.6

—

Sleep apnoea

2.77

1.38

1.2

1.6

—

Neurotic, stress-related and somatoform disorders

2.25

1.37

1.3

1.5

—

Anxiety disorders

2.24

1.37

1.3

1.5

—

Injuries to the ankle and foot

2.17

1.36

1.4

—

Congenital malformations and deformations of the musculoskeletal system

2.60

1.36

1.3

1.5

—

Conductive and sensorineural hearing loss

2.70

1.35

1.2

1.5

—

Dentofacial anomalies [including malocclusion]

2.19

1.35

1.2

1.4

—

Other (not insulin) diabetes medications

2.74

1.34

1.0

1.2

—

Inguinal hernia

2.67

1.33

1.3

—

Diseases of the skin and subcutaneous tissue

2.28

1.33

1.8

1.3

—

Type 2 diabetes, strict (exclude DM1)

2.71

1.32

1.0

1.2

—

Type 2 diabetes, definitions combined

2.71

1.32

1.0

1.2

—

Hypertensive diseases

2.21

1.32

1.6

1.4

—

Type 2 diabetes

2.70

1.32

1.0

1.2

—

Hypertensive diseases (excluding secondary)

2.45

1.31

1.6

1.5

—

Nutritional anaemias

2.51

1.30

1.3

1.4

—

Other diseases of urinary system

1.97

1.29

1.4

—

Bacterial pneumonia (organism specified)

2.83

1.29

1.8

1.6

—

Symptoms and signs involving the nervous and musculoskeletal systems

2.35

1.29

1.8

1.4

—

Other and unspecified urticaria

2.78

1.28

1.2

1.6

—

Other and unspecified iron deficiency

2.78

1.28

1.4

1.5

—

Pollen allergy

2.32

1.28

1.4

—

Other arrhythmias

2.51

1.27

1.0

1.6

—

Other diseases of hard tissues of teeth

2.59

1.24

1.5

1.3

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2.39

1.23

1.5

1.6

—

Polycystic ovarian syndrome, consortium definition

2.26

1.23

1.1

1.5

—

Dermatitis due to ingested food

2.67

1.22

1.0

1.4

—

Other antidepressants

2.28

1.22

1.0

1.7

—

Type 2 diabetes, definitions combined, including avohilmo

2.50

1.21

1.0

1.4

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2.64

1.18

1.0

1.5

—

Congenital malformations and deformations of the musculoskeletal system

2.30

1.17

1.3

1.5

—

Gingivitis and periodontal diseases

2.03

1.15

1.5

1.4

—

Transport accidents

2.53

1.14

1.4

—

Persons encountering health services in other circumstances

2.49

1.14

1.2

1.5

—

Benzodiazepine use

2.04

1.12

1.0

1.5

—

Neonatal jaundice from other and unspecified causes

2.43

1.11

1.0

1.4

—

Polyarthropathies

2.29

1.10

1.1

1.6

—

Visual disturbances and blindness

2.26

1.10

1.3

1.5

—

Dental operations

2.57

1.08

1.0

1.1

—

Complications of surgical and medical care, not elsewhere classified

2.05

1.07

1.3

1.4

—

Atopic dermatitis, strict definition with reimbursement

2.11

1.05

1.7

1.3

—

Chronic periodontitis, including avohilmo

2.39

1.05

1.4

1.5

—

Periodontitis

2.39

1.04

1.4

1.5

—

Exposure to other specified factors

1.97

1.03

1.2

1.5

—

Other and unspecified dermatitis

2.27

1.03

1.6

1.5

—

Endocrine, nutritional and metabolic diseases

1.92

1.02

1.3

—

Iron deficiency anaemia

2.24

1.01

1.4

1.5

—

Unspecified fall

1.97

0.98

1.6

1.4

—

Biguanides

2.44

0.98

1.0

1.4

—

Pregnancy with abortive outcome

2.41

0.97

1.2

1.5

—

Heart failure, not strict

2.26

0.94

1.5

1.4

—

Hyperkinetic disorders

2.26

0.94

1.2

1.5

—

Obesity

2.14

0.91

1.5

—

Obesity and other hyperalimentation

2.14

0.91

1.5

—

Cystitis

1.86

0.89

1.3

1.4

—

Gastro-oesophageal reflux disease

2.07

0.89

1.3

1.4

—

Conjunctivitis (acute, non atopic)

2.06

0.89

1.7

1.3

—

Other disorders of urethra and urinary system

2.06

0.88

1.3

1.4

—

Episodal and paroxysmal disorders

1.70

0.86

1.5

1.3

—

Percutaneous Coronary Intervention

1.82

0.85

1.4

1.5

—

Coronary revascularization (ANGIO or CABG)

1.81

0.85

1.4

1.5

—

Abdominal and pelvic pain

1.78

0.84

1.5

1.3

—

Emergency coronary revascularization (for ACS)

1.80

0.84

1.4

1.5

—

Major coronary heart disease event

1.79

0.84

1.4

1.5

—

Delivery

0.00

0.83

0.0

1.6

—

Single spontaneous delivery

0.00

0.83

0.0

1.6

—

Atopic dermatitis

1.77

0.83

1.6

1.3

—

Neurological diseases

1.72

0.83

1.4

1.3

—

Artificial joint operation, meniscal resection

0.00

0.81

0.0

1.5

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.68

0.80

1.5

1.4

—

Diseases of pulp and periapical tissues, including avohilmo

1.68

0.78

1.7

1.4

—

Pain in joint

2.28

0.78

1.4

1.2

—

Diseases of the musculoskeletal system and connective tissue

1.74

0.77

1.9

1.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

2.14

0.75

1.6

1.3

—

Migraine

2.13

0.75

1.4

1.5

—

Diseases of oesophagus, stomach and duodenum

1.68

0.75

1.2

1.4

—

Dizziness and giddiness

2.09

0.74

1.6

—

Disorders of skin appendages

2.08

0.74

1.2

1.5

—

Crowding of teeth, including avohilmo

2.07

0.74

1.6

1.5

—

Medical abortion

2.09

0.74

1.2

1.5

—

Autoimmune diseases excluding thyroid diseases

1.64

0.73

1.5

1.4

—

Intracranial injury

1.79

0.72

1.1

1.4

—

Mood disorders, excluding more controls

1.99

0.71

1.4

1.3

—

Diseases of the ear and mastoid process

1.73

0.71

1.5

1.3

—

Other heart diseases

1.76

0.71

1.6

1.5

—

Inflammatory diseases of female pelvic organs

1.93

0.70

1.2

1.5

—

Septal defects

1.88

0.69

1.2

1.4

—

Dermatitis

1.84

0.68

1.6

1.4

—

Visual disturbances

1.79

0.66

1.4

1.5

—

Diseases of oral cavity, salivary glands and jaws

1.84

0.66

1.6

1.2

—

Mood [affective] disorders

1.62

0.65

1.3

1.5

—

Mood disorders

1.62

0.65

1.3

1.5

—

Sleep disorders (combined)

1.75

0.65

1.1

1.5

—

Ischemic heart diseases

1.72

0.64

1.4

1.5

—

Other heart diseases, wide

1.60

0.64

1.4

—

Pain in limb

1.63

0.63

1.5

1.3

—

Artrosis, including avohilmo

0.00

0.63

0.0

1.4

—

Arthropathies

1.59

0.61

1.3

1.5

—

Other external causes of accidental injury

1.50

0.55

1.4

1.3

—

Injuries to the wrist and hand

1.52

0.55

1.6

1.4

—

Depression

1.51

0.51

1.3

1.5

—

Chronic apical periodontitis

1.59

0.50

2.0

1.3

—

Injury, poisoning and certain other consequences of external causes

1.46

0.47

1.0

1.4

—

Dermatitis and eczema

1.48

0.44

1.6

1.3

—

Fall on same level

0.64

0.44

1.2

1.4

—

Hypothyroidism, strict autoimmune

1.64

0.44

1.4

1.5

—

Diabetes medication

1.44

0.43

1.4

1.5

—

Pregnancy, childbirth and the puerperium

0.00

0.43

0.0

1.4

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.60

0.43

1.0

1.5

—

Diabetes, varying definitions

1.42

0.43

1.4

1.5

—

Diabetes mellitus

1.42

0.43

1.4

1.5

—

Delivery, wide proxy

0.00

0.42

0.0

1.5

—

Superficial injury of head

0.00

0.41

0.0

1.4

—

False labour

0.00

0.41

0.0

1.5

—

Sleep disorders

1.44

0.39

1.0

1.5

—

Exposure to unspecified factor

1.32

0.38

1.3

1.4

—

Autoimmune diseases

1.40

0.37

1.5

1.3

—

Other specific joint derangements/joint disorders

1.38

0.35

1.3

1.5

—

Dental caries, including avohilmo

1.33

0.34

1.5

1.2

—

Accidents

1.34

0.29

1.5

1.3

—

Other joint disorders

1.28

0.28

1.3

1.5

—

Other soft tissue disorders, not elsewhere classified

1.26

0.26

1.6

1.4

—

Soft tissue disorders

1.29

0.24

1.5

1.3

—

Diseases of pulp and periapical tissues and dental caries

1.28

0.23

1.6

1.2

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.25

0.22

1.4

1.5

—

Diabetic retinopathy

0.00

0.22

0.0

1.4

—

Heart failure, strict

0.00

0.22

0.0

1.5

—

All-cause Heart Failure

0.00

0.22

0.0

1.5

—

Transient ischemic attack

0.00

0.21

0.0

1.7

—

Rotator cuff syndrome

0.00

0.21

0.0

1.2

—

Pain and other conditions associated with female genital organs and menstrual cycle

0.00

0.21

0.0

1.5

—

Benign neoplasm of colon, rectum, anus and anal canal

0.00

0.21

0.0

1.3

—

Long labour

0.00

0.21

0.0

1.4

—

Bleeding

1.18

0.21

1.8

1.4

—

Haemorrhage in early pregnancy

0.00

0.21

0.0

1.2

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.21

0.0

1.4

—

Gestational [pregnancy-induced] hypertension

0.00

0.21

0.0

1.3

—

Migraine without aura and triptan purchases

0.00

0.21

0.0

2.0

—

Schizophrenia or delusion

0.00

0.21

0.0

1.5

—

Schizophrenia, schizotypal and delusional disorders

0.00

0.21

0.0

1.5

—

Kela-code for severe mental illness

0.00

0.21

0.0

1.5

—

Gonarthrosis

0.00

0.21

0.0

1.3

—

Maternal care for known or suspected abnormality of pelvic organs

0.00

0.21

0.0

1.4

—

Suicide or other Intentional self-harm

0.00

0.21

0.0

1.7

—

Pre-eclampsia or poor fetal growth

0.00

0.21

0.0

1.3

—

Pedal cyclist injured in transport accident

0.00

0.21

0.0

1.7

—

Any event in cancer register

1.22

0.20

1.8

1.2

—

Overjet

0.00

0.20

0.0

1.7

—

Distal bite

0.00

0.20

0.0

1.8

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.20

0.20

1.5

—

Used for control exclusion in common control thyroid runs

1.26

0.20

1.5

1.3

—

Finngen Rheumatological endpoints

1.24

0.19

1.6

1.4

—

Neoplasms

1.23

0.17

1.6

1.3

—

Injuries to the head

1.11

0.15

1.2

1.4

—

Injuries to the elbow and forearm

1.13

0.10

1.0

1.5

—

Malignant neoplasm

1.10

0.10

2.0

1.3

—

Hypothyroidism, other/unspecified

1.10

0.10

1.4

1.5

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.07

0.09

1.0

1.5

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.06

0.09

1.4

1.5

—

Malignant neoplasm, wide definition for exclusion

1.05

0.09

2.0

1.3

—

External causes of morbidity and mortality

1.11

0.09

1.3

1.4

—

Pain (limb, back, neck, head abdominally)

1.11

0.09

1.3

1.2

—

Diabetes, insulin treatment (Kela reimbursement)

1.13

0.09

1.5

1.4

—

Caries of dentine, including avohilmo

0.82

0.08

1.8

1.2

—

Constipation

1.08

0.08

1.4

—

Injuries to the knee and lower leg

1.08

0.07

1.5

1.4

—

Falls/tendency to fall

1.05

0.07

1.6

1.3

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

0.0

1.8

—

Spondyloarthritis

0.00

0.0

1.6

—

Thyrotoxicosis, other and/or unspecified

0.00

0.0

1.8

—

Thyrotoxicosis

0.00

0.0

1.7

—

Coxarthrosis

0.00

0.0

1.3

—

Fibroblastic disorders

0.00

0.0

1.0

—

Subjective visual disturbances

0.00

0.0

1.6

—

Malignant neoplasm of breast, HER-positive

0.00

0.0

1.6

—

Abrasion of teeth

0.00

0.0

1.7

—

Other sexually transmitted chlamydial diseases

0.00

0.0

1.6

—

Malignant neoplasm of brain, including Hilmo

0.00

0.0

1.0

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

-0.00

0.0

2.0

—

Other disorders of eye and adnexa

0.00

-0.00

0.0

1.5

—

Pre-eclampsia or eclampsia

0.00

-0.00

0.0

1.4

—

Disorders of the thyroid gland

0.99

-0.00

1.4

—

Disorders of muscles

0.00

-0.00

0.0

1.6

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

-0.00

0.0

1.6

—

Post-traumatic stress disorder

0.00

-0.00

0.0

1.4

—

Congenital malformations of larynx

0.00

-0.00

0.0

1.8

—

Soft tissue disorders related to use, overuse and pressure

0.00

-0.00

0.0

1.0

—

Diabetic nephropathy

0.00

-0.00

0.0

1.6

—

Blepharochalasis

0.00

-0.00

0.0

1.6

—

Thyrotoxicosis with diffuse goitre

0.00

-0.00

0.0

1.0

—

Benign neoplasm of ovary

0.00

-0.00

0.0

1.4

—

Other and unspecified nonorganic psychotic disorders

0.00

-0.00

0.0

1.7

—

Medicines for HER+ breast cancer

0.00

-0.00

0.0

1.4

—

Diabetic retinopathy, strict definition

0.00

-0.00

0.0

1.6

—

Crushed, pushed or stepped on by crowd or human stampede

0.00

-0.00

0.0

1.5

—

Dislocation, sprain and strain of joints and ligaments of elbow

0.00

-0.00

0.0

1.5

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

0.00

-0.00

0.0

1.6

—

Emotionally unstable personality disorder

0.00

-0.00

0.0

1.6

—

Malignant neoplasm of breast, ER-positive, including Hilmo

0.00

-0.00

0.0

1.6

—

Diaphragmatic hernia

0.00

-0.00

0.0

1.4

—

Other disorders of patella

0.00

-0.00

0.0

1.9

—

Obsessive-compulsive disorder

0.00

-0.00

0.0

1.9

—

Trigger finger

0.00

-0.00

0.0

1.0

—

Hallux valgus (acquired)

0.00

-0.00

0.0

1.4

—

Anorexia (incl.atypical)

0.00

-0.00

0.0

1.7

—

Superficial injury of forearm

0.00

-0.00

0.0

1.9

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

0.00

-0.00

0.0

1.0

—

Abnormalities of forces of labour

0.00

-0.00

0.0

1.6

—

Endometriosis ASRM stages 3,4

0.00

-0.00

0.0

1.4

—

Ganglion

0.00

-0.00

0.0

1.4

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

0.00

-0.00

0.0

1.8

—

Heart failure,strict

0.00

-0.00

0.0

1.6

—

Fracture of skull and facial bones

0.00

-0.00

0.0

1.5

—

Hydrocele

0.00

-0.00

0.0

1.5

—

Retinal detachments and breaks

0.00

-0.00

0.0

1.4

—

L02BG Aromatase inhibitors

0.00

-0.00

0.0

1.6

—

Pre-eclampsia

0.00

-0.00

0.0

1.4

—

Foreign body in alimentary tract

0.00

-0.00

0.0

1.6

—

Hypertrophy of breast

0.00

-0.00

0.0

1.4

—

Hyperkinetic disorders (excl. ADHD)

0.00

-0.00

0.0

1.7

—

Outcome of delivery

0.00

-0.00

0.0

1.5

—

Injury of eye and orbit

0.00

-0.00

0.0

1.8

—

Hypertrophy of breast in women and men

0.00

-0.00

0.0

1.3

—

Liveborn infants according to place of birth

0.00

-0.00

0.0

1.3

—

Prolonged pregnancy

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Colon

0.00

-0.00

0.0

1.4

—

Injury of unspecified body region

0.00

-0.00

0.0

1.6

—

Impacted maxillary molar

0.00

-0.00

0.0

2.0

—

Pedal cyclist injured in noncollision transport accidents

0.00

-0.00

0.0

1.6

—

Fall involving playground equipment

0.00

-0.00

0.0

1.6

—

Bipolar affective disorders

0.00

-0.00

0.0

1.7

—

Poor fetal growth

0.00

-0.00

0.0

1.2

—

Schizophrenia or delusion, excluding more controls

0.00

-0.00

0.0

1.8

—

Exclusions for E4_PCOS_CONSORTIUM

0.94

-0.00

1.3

1.4

—

Pervasive developmental disorders excl. Autism + Asperger

0.00

-0.00

0.0

1.3

—

Abnormal findings on antenatal screening of mother

0.00

-0.00

0.0

1.0

—

Gonarthrosis, primary, with knee surgery

0.00

-0.00

0.0

1.4

—

Ectopic testis

0.00

-0.00

0.0

1.7

—

Benign neoplasms

0.97

-0.00

1.3

1.4

—

Coronary atherosclerosis

0.00

-0.00

0.0

1.6

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Haemophilus influenzae B Ab [Mass/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS